证券代码：688389 证券简称：普门科技 公告编号：2026-009 深圳普门科技股份有限公司 董事会薪酬与考核委员会关于公司2026年股票期权 激励计划激励对象名单的公示情况说明及核查意见 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳普门科技股份有限公司（以下简称"公司"）于2026年1月19日召开了 第三届董事会第二十一次会议，审议通过了《关于〈公司2026年股票期权激励计 划（草案）〉及其摘要的议案》等相关议案。根据《中华人民共和国公司法》（以 下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《上 市公司股权激励管理办法》（以下简称《管理办法》）、《上海证券交易所科创 板股票上市规则》（以下简称《上市规则》）、《科创板上市公司自律监管指南 第4号——股权激励信息披露》（以下简称《监管指南》）等的相关规定，公司 对2026年股票期权激励计划激励对象名单在公司内部进行了公示。公司董事会薪 酬与考核委员会（以下简称"薪酬与考核委员会"）结合公示情况对拟激励对象 进行了核查，相关公示情况及核查情 ...

深圳普门科技股份有限公司 2026 年第一次临时股东会 证券代码：688389 证券简称：普门科技 深圳普门科技股份有限公司 2026 年第一次临时股东会 会议资料 二〇二六年二月五日 为保障深圳普门科技股份有限公司（以下简称"公司"或"普门科技"）全 体股东的合法权益，维护股东会的正常秩序，保证股东会的议事效率，确保本次 股东会如期、顺利召开，根据《中华人民共和国公司法》《深圳普门科技股份有 限公司章程》《深圳普门科技股份有限公司股东会议事规则》及中国证券监督管 理委员会、上海证券交易所的有关规定，特制定本须知。 一. 股东会设会务组，由公司董事会秘书负责会议的程序安排和会务工作。 二. 为保证本次股东会的严肃性和正常秩序，切实维护与会股东（或股东代理人） 的合法权益，除出席会议的股东（或股东代理人）、公司董事、高级管理人 员、见证律师及董事会邀请的人员外，公司有权依法拒绝其他人员进入会场。 三. 请出席会议的股东（或股东代理人）在会议召开前 30 分钟到会议现场办理 签到手续，并请按规定出示股东账户卡、身份证或法人单位证明、授权委托 书等，经验证后领取会议资料，方可出席会议。会议开始后，由会议主持人 宣布 ...

证券之星消息，1月27日医疗器械板块较上一交易日下跌0.68%，硕世生物领跌。当日上证指数报收于 4139.9，上涨0.18%。深证成指报收于14329.91，上涨0.09%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300639 | 凯普生物 | 8.70 | 20.00% | 173.48万 | | 14.29 乙 | | 002030 | 达安基因 | 7.71 | 9.99% | 271.53万 | | 20.71亿 | | 002901 | 大博医疗 | 51.90 | 7.45% | 7.24万 | | 3.71亿 | | 688607 | 康众医疗 | 66.99 | 6.91% | 5.11万 | | 3.30亿 | | 300289 | 利德曼 | 8.10 | 5.19% | 49.26万 | | 3.84亿 | | 688613 | 奥精医疗 | 24.51 | 5.19% | 7.92万 | | 2688T | | 68 ...

Group 1 - The company, Pumen Technology, stated that it is managing daily operational needs while considering cash costs and the allocation of cash and short-term loans [1] - The company aims to improve capital efficiency by appropriately utilizing financial leverage while maintaining financial stability [1]

Group 1 - The company held its 21st meeting of the third board of directors on January 19, 2026, with all 9 directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the draft of the 2026 stock option incentive plan to optimize governance structure and attract talent, aligning interests of shareholders, the company, and core team members [2][3] - The board's decision on the stock option incentive plan was supported by the remuneration and assessment committee prior to the meeting [3] Group 2 - The board also approved the management measures for the implementation of the 2026 stock option incentive plan, ensuring smooth execution in accordance with relevant laws and regulations [6][7] - The board proposed to authorize the board to handle matters related to the stock option incentive plan, including determining eligibility, adjusting stock options, and managing the exercise of options [9][10][12] - The board unanimously agreed to appoint a securities affairs representative, Ms. Zhai Roumei, for the term until the end of the current board's tenure [14][15] - The board agreed to convene the first temporary shareholders' meeting of 2026 on February 5, 2026, utilizing both on-site and online voting methods [16][17]

Core Viewpoint - The company has been actively exporting and selling products to EU member states, achieving market access and sales for multiple products [1] Group 1: Business Operations - The company primarily employs an indirect sales model, supplemented by direct sales [1] - Indirect sales involve selling products through distributors and general indirect sales customers to end clients [1]

证券日报网讯1月21日，普门科技在互动平台回答投资者提问时表示，如有回购、增持等相关计划，公 司将按照法律法规及时履行信息披露义务。 ...

Core Viewpoint - The company, Pumen Technology, is actively integrating AI technology into its medical device products and services to enhance their intelligence and clinical value [2] Group 1: AI Integration in Product Development - The company is utilizing AI algorithms in its fully automated chemiluminescence immunoassay analyzers, eCL8600 and eCL8800 series, to improve detection efficiency through precise recognition of barcodes and container types [2] - In the field of dermatology and aesthetic medicine, the company has applied AI skin detection technology to semiconductor laser hair removal devices, ensuring safety for both patients and operators while enhancing operational convenience [2] Group 2: Operational Efficiency - The company is leveraging AI platforms to empower various operational systems, thereby improving overall business efficiency [2]

证券代码：688389 证券简称：普门科技 公告编号：2026-008 深圳普门科技股份有限公司 第三届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 深圳普门科技股份有限公司（以下简称"公司"）于 2026 年 1 月 19 日以 现场会议方式召开了第三届董事会第二十一次会议。本次会议通知已于 2026 年 1 月 16 日以电话、邮件等形式送达公司全体董事。本次会议由董事长刘先成先 生召集并主持，会议应参加董事 9 人，实际参加董事 9 人，公司高级管理人员 列席本次会议。本次会议的召集、召开程序符合有关法律法规和《公司章程》 的相关规定。 二、董事会会议审议情况 经全体董事表决，形成决议如下： （一）审议通过《关于〈公司 2026 年股票期权激励计划（草案）〉及其摘 要的议案》 为了进一步优化公司治理结构，健全公司长效激励机制，吸引和留住优秀 人才，充分调动公司核心团队的积极性，有效地将股东利益、公司利益和核心 团队个人利益结合在一起，使各方共同关注和推动公司的长 ...

Market Overview - The Shanghai Composite Index closed at 4120.10 points, above the annual line, with a change of 0.16% [1] - The total trading volume of A-shares reached 1,645.83 billion yuan [1] Stocks Above Annual Line - A total of 61 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Huawi Design (华维设计) with a deviation rate of 24.42% - Hualing Co. (华岭股份) at 5.51% - Huilong Piston (汇隆活塞) at 4.81% [1] Detailed Stock Performance - The following table summarizes the performance of selected stocks that have crossed the annual line: - Huawi Design (华维设计): Today's change of 29.96%, turnover rate of 26.39%, annual line at 14.64 yuan, latest price at 18.22 yuan [1] - Hualing Co. (华岭股份): Today's change of 12.70%, turnover rate of 9.21%, annual line at 24.90 yuan, latest price at 26.27 yuan [1] - Huilong Piston (汇隆活塞): Today's change of 18.06%, turnover rate of 13.30%, annual line at 9.86 yuan, latest price at 10.33 yuan [1] - Other notable stocks include: - Wuhan Fangu (武汉凡谷) with a deviation rate of 4.17% - Meirui New Materials (美瑞新材) with a deviation rate of 3.81% [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Gongdong Medical (拱东医疗) and Chongqing Gas (重庆燃气) [1] - The performance of these stocks indicates a cautious upward trend in the market [1]